Welcome!

.NET Authors: JP Morgenthal, Bob Gourley, Yung Chou, Adine Deford, Jim Kaskade

News Feed Item

Financial Standings, Corporate Credit Ratings, Upcoming Conferences, and Company Restructuring - Analyst Notes on Weingarten Realty, Liberty Property, BioMed Realty, Taubman, and CommonWealth REIT

Editor Note: For more information about this release, please scroll to bottom.

NEW YORK, April 4, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Weingarten Realty Investors (NYSE: WRI), Liberty Property Trust (NYSE: LPT), BioMed Realty Trust Inc. (NYSE: BMR), Taubman Centers Inc. (NYSE: TCO), and CommonWealth REIT (NYSE: CWH). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

--

Weingarten Realty Investors Analyst Notes 

On April 1, 2014, Weingarten Realty Investors (Weingarten Realty) stock increased 1.30%, ending the day at $30.39. Over the previous five trading sessions, shares of Weingarten Realty increased 2.22% compared to the Dow Jones Industrial Average which also increased 1.01% during the same period. The full analyst notes on Weingarten Realty Investors are available to download free of charge at:

http://www.AnalystsReview.com/04042014/WRI/report.pdf

--

Liberty Property Trust Analyst Notes 

On April 1, 2014, Liberty Property Trust (Liberty Property) stock increased 0.54%, ending the day at $37.16. For the past month, shares of Liberty Property declined 2.87%, compared to the Dow Jones Industrial Average which increased 1.29% during the same period. The full analyst notes on Liberty Property Trust are available to download free of charge at:

http://www.AnalystsReview.com/04042014/LPT/report.pdf


--

BioMed Realty Trust Inc. Analyst Notes 

On March 31, 2014, BioMed Realty Trust Inc. (BioMed Realty) reported that the Company's rating outlook on its investment grade corporate credit rating from Moody's Investors Service was revised to positive from stable. Greg N. Lubushkin, Chief Financial Officer of BioMed Realty, commented, "We are very pleased with the positive outlook from Moody's which reflects the sustained, systematic enhancement of our credit quality since we became the first life science real estate investment trust to receive an investment grade corporate credit rating in 2010. In addition, the recent Moody's and S&P actions validate our steady approach to growing our industry-leading portfolio, as well as our proven track record of executing a sound, long-term capital strategy which enables us to better serve the life science communities in the United States and United Kingdom." The full analyst notes on BioMed Realty Trust Inc. are available to download free of charge at:

http://www.AnalystsReview.com/04042014/BMR/report.pdf

--

Taubman Centers Inc. Analyst Notes 

On March 21, 2014, Taubman Centers Inc. (Taubman) declared that it will release its Q1 2014 earnings after the market closing on April 24, 2014. Taubman will also hold a conference call to review the results on April 25, 2014 at 11:00 a.m. EDT. Interested parties can access a live broadcast of the conference call online at the Investor section of the Company website, where an online replay will also be available for at least 90 days. The full analyst notes on Taubman Centers Inc. are available to download free of charge at:

http://www.AnalystsReview.com/04042014/TCO/report.pdf


--

CommonWealth REIT Analyst Notes 

On March 25, 2014, CommonWealth REIT reported that it confirmed that Related Fund Management LLC and Corvex Management LP delivered to CWH written consents reaching the 66.7% threshold necessitated the removal of remove the entire CWH Board of Trustees, without cause, and all CWH Trustees have been removed. In accordance with the November 18, 2013 Arbitration Panel order and CWH's Declaration of Trust, the officers of CWH will immediately call a special meeting of shareholders in order to elect new Trustees to the CWH Board. The Company will file a preliminary information statement for the special meeting with the Securities & Exchange Commission (SEC) within one week as required by federal securities laws. The Company shall hold the special meeting on or before Friday, May 23, 2014, subject to the timely completion of the required SEC regulatory review of the information statement. CWH will declare the time, date and place of the special meeting and the record date therefor concurrently with filing the definitive information statement with the SEC. The full analyst notes on CommonWealth REIT are available to download free of charge at:

http://www.AnalystsReview.com/04042014/CWH/report.pdf


--

About Analysts Review
We provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

--


=============

EDITOR NOTES: 

  • This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  • Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  • This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  • If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] AnalystsReview.com.
  • For any urgent concerns or inquiries, please contact us at compliance [at] AnalystsReview.com.
  • Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] AnalystsReview.com for consideration.

COMPLIANCE PROCEDURE 

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the Procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE 

Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED 

Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


AnalystsReview.com

SOURCE Analysts Review

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.